Phase 3 Recruiting NIH
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT04267848
Sites in New Mexico: - Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico
- University of New Mexico Cancer Center — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Presbyterian Rust Medical Center/Jorgensen Cancer Center — Rio Rancho, New Mexico
Phase 3 Recruiting NIH
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT04181060
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
- New Mexico Oncology Hematology Consultants — Albuquerque, New Mexico
Phase 3 Recruiting Academic/Other
This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or target…
Sponsor: NRG Oncology
NCT ID: NCT05624996
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Memorial Medical Center-Las Cruces — Las Cruces, New Mexico
- Presbyterian Rust Medical Center/Jorgensen Cancer Center — Rio Rancho, New Mexico
Phase 3 Recruiting Industry
This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-sm…
Sponsor: Pfizer
NCT ID: NCT07222566
Sites in New Mexico: - University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
- CHRISTUS St. Vincent Regional Cancer Center — Santa Fe, New Mexico
Phase 3 Recruiting Industry
The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD…
Sponsor: Bristol-Myers Squibb
NCT ID: NCT06561386
Sites in New Mexico: - Local Institution - 0381 — Albuquerque, New Mexico
Phase 3 Recruiting Industry
The primary objectives are to compare progression-free survival (PFS) and overall survival (OS) in participants who receive sotorasib with platinum doublet chemotherapy versus participants who receive pembrolizumab with platinum doublet ch…
Sponsor: Amgen
NCT ID: NCT05920356
Sites in New Mexico: - University of New Mexico Cancer Center — Albuquerque, New Mexico
Phase 3 Recruiting Industry
The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab with Carboplatin plus Etoposide as Fir…
Sponsor: Bristol-Myers Squibb
NCT ID: NCT06646276
Sites in New Mexico: - University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
Phase 3 Recruiting Industry
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (E…
Sponsor: Gilead Sciences
NCT ID: NCT06801834
Sites in New Mexico: - New Mexico Oncology Hematology Consultants, Ltd — Albuquerque, New Mexico
Phase 2 Recruiting Industry
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other…
Sponsor: Reunion Neuroscience Inc
NCT ID: NCT07002034
Sites in New Mexico: - University of New Mexico, School of Medicine — Albuquerque, New Mexico
Phase 1, Phase 2 Recruiting Industry
This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents
Sponsor: AstraZeneca
NCT ID: NCT05123482
Sites in New Mexico: - Research Site — Albuquerque, New Mexico
Recruiting Academic/Other
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…
Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in New Mexico: - Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico
- University of New Mexico Cancer Center — Albuquerque, New Mexico
- Lovelace Women's Hospital — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Memorial Medical Center-Las Cruces — Las Cruces, New Mexico
Recruiting Academic/Other
This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …
Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in New Mexico: - Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico
- University of New Mexico Cancer Center — Albuquerque, New Mexico
- Lovelace Women's Hospital — Albuquerque, New Mexico
- Presbyterian Kaseman Hospital — Albuquerque, New Mexico
- Memorial Medical Center-Las Cruces — Las Cruces, New Mexico
Recruiting Industry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…
Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in New Mexico: - Massive Bio SYNERGY-AI site — Albuquerque, New Mexico
Recruiting Industry
The primary objective of this study is to compare Assay results to diagnoses determined by currently accepted standards for lung cancer detection. This will be accomplished by analysis of sputum samples from three cohorts including healthy…
Sponsor: bioAffinity Technologies Inc.
NCT ID: NCT03457415
Sites in New Mexico: - Radiology Associates of Albuquerque — Albuquerque, New Mexico